What is Bernell?
Bernell is a prominent provider of comprehensive ophthalmic products and vision therapy solutions, serving healthcare professionals such as optometrists, ophthalmologists, and occupational therapists. The company boasts an extensive catalog of over 2,000 products, addressing primary eye care and vision testing needs. Notably, Bernell offers the world's largest selection of vision therapy and visual rehabilitation products, aiming to develop and market unique solutions for global vision care. Their clientele extends to educational institutions and government bodies, facilitating access to critical eye care resources.
How much funding has Bernell raised?
Bernell has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Bernell?
The substantial late-stage funding indicates Bernell is poised for significant scaling and market expansion. This capital injection is likely to fuel further product development, enhance distribution networks, and potentially explore new therapeutic areas within vision science. The company's strategic focus on providing a wide array of specialized vision care solutions positions it for continued growth and leadership in the global eye health sector.
See full Bernell company page
